<img height="1" width="1" src="https://www.facebook.com/tr?id=769125799912420&amp;ev=PageView &amp;noscript=1">
About Our People Legal Stuff Careers
FDA Logo

FDA issues warning about serious genital infection with certain type 2 diabetes medicines


by Caitlyn Shelton

(FOX17)--The U.S. Food and Drug Administration has issued a warning that cases of a rare, but serious infection of the genitals have been reported with a class of type 2 diabetes medicines.

Cases of Fournier's gangrene have been reported with SGLT2 inhibitors. The certain kind of inhibitors are used to lower blood sugar in adults with type 2 diabetes. Fournier’s gangrene is a life-threatening bacterial infection of the tissue under the skin that surrounds muscles, nerves, fat and blood vessels of the perineum. The bacteria usually enters the body through a cut or break in the skin, where they spread and destroy tissue.

In five years, the FDA has identified 12 cases of Fournier’s gangrene in patients taking an SGLT2 inhibitor. All 12 patients were hospitalized, and one patient died.

The FDA says 1.7 million patients received a dispensed prescription for an SGLT2 inhibitor.

Officials say anyone experiencing side effects involving SGLT2 inhibitors should contact their doctor and report it to the FDA MedWatch program by calling 1-800-332-1088.

Find more information about the warning here.

Read Comments
Facebook Twitter Instagram Pinterest Linked In List Menu Enlarge Gallery Info Menu Close Angle Down Angle Up Angle Left Angle Right Grid Grid Play Align Left Search Youtube Mail Mail Angle Down Bookmark